Clinical relevance of starting alectinib at a reduced dose in patients with ALK-positive non-small cell lung cancer.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Junkyu Kim, Min-Ji Kim, Jinyong Kim, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Jong-Mu Sun
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410805004